00
Days
00
Hrs
00
Min
00
Sec
Submit Your Paper

The Impact of Generative AI on the Efficiency and Accuracy of Drug Discovery

Authors

Harsha Rajurkar

Department of Computer Science and Engineering M.S. Bidve Engineering College, Latur. (IN)

Article Information

DOI: N/A

Subject Category: Generative AI

Volume/Issue: 15/13 | Page No: 2770-2774

Publication Timeline

Submitted: 2026-06-21

Published: 2026-06-18

Abstract

Drug discovery traditionally is a long and expensive process. It requires huge financial investment and can possibly take more than a decade to develop a single drug. In this paper, It has been explored how generative AI is changing this process. By using advanced models, generative AI can design new drug molecules, predict their properties, improve efficiency by reducing both time and cost required for research to get precise and accurate data. These models can generate drug candidates with better binding affinity and drug like properties, making the selection process more reliable. It is also being used across different stages of drug discovery, from identifying targets to monitoring drug safety. Although generative AI has great potential to transform drug discovery by making it faster, more efficient and accurate, there are still some challenges like the need for high quality data, lack of model transparency, regulatory concerns and more real world testing and comparison. These improvements are still needed for its full adoption.

Keywords

Predictive Modeling, Cost Reduction, Time Optimization, Molecular Design, Drug Discovery, Generative AI

Downloads

References

1. Kadan, A., Ryczko, K., Lloyd, E., Roitberg, A., & Yamazaki, T. (2025). Guided multi-objective generative AI to enhance structure-based drug design. In Chemical Science (Vol. 16, Issue 29, pp. 13196–13210). Royal Society of Chemistry (RSC). https://doi.org/10.1039/d5sc01778e [Google Scholar] [Crossref]

2. Obi, P., Gc, J. B., Mariasoosai, C., Diyaolu, A., & Natesan, S. (2024). Application of Generative Artificial Intelligence in Predicting Membrane Partitioning of Drugs: Combining Denoising Diffusion Probabilistic Models and MD Simulations Reduces the Computational Cost to One-Third. In Journal of Chemical Theory and Computation (Vol. 20, Issue 14, pp. 5866–5881). American Chemical Society (ACS). https://doi.org/10.1021/acs.jctc.4c00315 [Google Scholar] [Crossref]

3. Zhang, O., Lin, H., Zhang, H., Zhao, H., Huang, Y., Huang, Y., Jiang, D., Hsieh, C., Pan, P., & Hou, T. (2024). Deep Lead Optimization: Leveraging Generative AI for Structural Modification. Journal of the American Chemical Society. [Google Scholar] [Crossref]

4. Lai, L., Liu, Y., Song, B., Li, K., & Zeng, X. (2025). Deep Generative Models for Therapeutic Peptide Discovery: A Comprehensive Review. In ACM Computing Surveys (Vol. 57, Issue 6, pp. 1–29). Association for Computing Machinery (ACM). https://doi.org/10.1145/3714455 [Google Scholar] [Crossref]

5. Vora, D., Chan, A., Pangeni Pokharel, S., Liu, Q., Chen, R., Chen, B., Chen, A., Yang, L., & Chen, C.-W. (2025). CRISPR-tica.ai: A function-informed generative modeling pipeline for prioritizing drug discovery in AML. In Blood (Vol. 146, Issue Supplement 1, pp. 277–277). American Society of Hematology. https://doi.org/10.1182/blood-2025-277 [Google Scholar] [Crossref]

6. Bordukova, M., Makarov, N., Rodriguez-Esteban, R., Schmich, F., & Menden, M. P. (2023). Generative artificial intelligence empowers digital twins in drug discovery and clinical trials. In Expert Opinion on Drug Discovery (Vol. 19, Issue 1, pp. 33–42). Informa UK Limited. https://doi.org/10.1080/17460441.2023.2273839 [Google Scholar] [Crossref]

7. Vanier, A., Fernandez, J., Kelley, S., Alter, L., Semenzato, P., Alberti, C., Chevret, S., Costagliola, D., Cucherat, M., Falissard, B., Gueyffier, F., Lambert, J., Lengliné, E., Locher, C., Naudet, F., Porcher, R., Thiébaut, R., Vray, M., Zohar, S., … Le Guludec, D. (2023). Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health. In BMJ Evidence-Based Medicine (Vol. 29, Issue 1, pp. 1–5). BMJ. https://doi.org/10.1136/bmjebm-2022-112091 [Google Scholar] [Crossref]

8. Mishra, H. P., & Gupta, R. (2025). Leveraging Generative AI for Drug Safety and Pharmacovigilance. In Current Reviews in Clinical and Experimental Pharmacology (Vol. 20, Issue 2, pp. 89–97). Bentham Science Publishers Ltd. https://doi.org/10.2174/0127724328311400240823062829 [Google Scholar] [Crossref]

9. Abbas, M. K. G., Rassam, A., Karamshahi, F., Abunora, R., & Abouseada, M. (2024). The Role of AI in Drug Discovery. In ChemBioChem (Vol. 25, Issue 14). Wiley. https://doi.org/10.1002/cbic.202300816 [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles

© 2026 IJLTEMAS · RSIS International. All rights reserved. ISSN 2278-2540.